[Corrigendum] Targeting cysteine‑rich angiogenic inducer‑61 by antibody immunotherapy suppresses growth and migration of non‑small cell lung cancer
Affiliations: Department of Respiration, Qilu Hospital of Shandong University, Jinan, Shandong 250012, P.R. China, Department of Respiration, Dezhou People's Hospital, Dezhou, Shandong 253014, P.R. China, Department of Cardiology, Dezhou People's Hospital, Dezhou, Shandong 253014, P.R. China
- Published online on: May 11, 2022 https://doi.org/10.3892/etm.2022.11365
- Article Number: 438
Copyright : © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].